semaglutide cardiovascular outcomes news 2025 october SOUL (Semaglutide cardiOvascular oUtcomes triaL) in individuals with Semaglutide and Cardiovascular Outcomes in

Although this database provides broad coverage of biomedical and psychiatric research, the exclusion of other sources (e.g., Embase, PsycINFO, Cochrane) may have limited the comprehensiveness of the review and introduced selection bias

She meticulously tracks your progress, offers personalized support for setbacks, and celebrates your milestones, providing a level of accountability, empathy, and clinical oversight that big-box programs can't provide

Addressing Vitamin B12 Deficiency Symptoms: Common symptoms include fatigue, anemia, neurological issues, and cognitive difficulties

Tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, has shown promise in the treatment of type 2 diabetes and obesity

Can oral chemotherapy cause liver or heart problems